AMTI - Applied Molecular Transport Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

0.00

Cash

52.2M

Avg Qtr Burn

N/A

Short % of Float

0.62%

Insider Ownership

21.36%

Institutional Own.

37.28%

Qtr Updated

12/31/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AMT-101 (IL-10 oral agonist) Details Ulcerative colitis, Rheumatoid arthritis, Pouchitis	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AMT-101 (IL-10 oral agonist) +anti-TNFα Details Rheumatoid arthritis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AMT-101 (IL-10 oral agonist) Details Ulcerative colitis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AMT-101 (IL-10 oral agonist) +anti-TNFα Details Ulcerative colitis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AMT-126 (IL-22) Details GI barrier repair	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.